May Meeting & CE

EMERGING TREATMENTS, NEWFOUND INDICATIONS, AND THE CLINICAL CONSIDERATIONS SURROUNDING ANTIDEPRESSANTS 

Presenter: Joshua Knebel, PharmD 

Assistant Professor UIW Feik School of Pharmacy 

Upon completion of this activity, pharmacists will be able to: 

1. Describe the clinical presentation and DSM-V diagnostic criteria for Generalized Anxiety Disorder (GAD) 

2. Discuss the pathophysiology of antidepressants/anti-anxiety agents and how emerging therapies are anxiolytic via their specific mechanism of action 

3. Identify which patients and anxiety disorders are the best candidates for emerging antidepressants and offlabel usage 

4. Report key counseling points and the most prevalent side effects for each psychotropic medication 

Upon completion of this activity, technicians will be able to: 

1. Describe the DSM-V diagnostic criteria for Generalized Anxiety Disorder (GAD) 

2. Discuss the pathophysiology of antidepressants and how they work via their specific mechanism of action 

3. Report key counseling points and the most prevalent side effects for each psychotropic medication 

Date/Time: Wednesday, May 22, 2024 from 7:00-8:00pm (Social/dinner starts at 6:30pm) 

Location: Feik School of Pharmacy Room: P1 Classroom (513) 

CPE Credit: 1.0 contact hours (UANs: 0445-9999-24-010-L01-P; 0445-9999-24-010-L01-T) 

Activity Type: Knowledge-based activity